Clinical Medicine Insights: Oncology ( IF 1.9 ) Pub Date : 2020-08-30 , DOI: 10.1177/1179554920953097 Lucy Haggstrom 1 , Gurdeep Parmar 2 , Daniel Brungs 1, 3
Objectives:
Central venous access is needed to facilitate chemotherapy for many cancer patients. Central venous catheter-related thrombosis (CVCT) is a major complication that can cause significant morbidity and mortality. We sought to explore the rate of CVCT in a general cancer population in Australia and to identify factors associated with increased risk of thrombosis.
Design:
This is a multi-centre retrospective cohort study.
Setting and participants:
We analysed key patient, treatment, and cancer-related factors for 317 patients with cancer and central venous catheters inserted for systemic therapy.
Main outcome measures:
Symptomatic CVCT confirmed with imaging and management of patients with CVCT.
Results:
A total of 402 cases of central line insertion were analysed. Central venous catheter-related thrombosis occurred in 24 patients (6.0%). Having a peripherally inserted central catheter (PICC; HR = 3.78, 95% CI = 1.28-11.19, P = .02) compared with an implantable port and a body mass index of ⩾25.0 kg/m2 (HR = 3.60, 95% CI = 1.31-9.85, P = .01) were independently associated with increased risk of thrombosis. Central venous catheter-related thrombosis was managed mostly with removal of the catheter (19 of 24 cases) and anticoagulation, including direct-acting oral anticoagulants in 5 patients.
Conclusions:
This work explored rates of CVCT in a general cancer population, observing increased rates in those with PICCs or increased body mass index.
中文翻译:
癌症中的中心静脉导管血栓形成:一项调查危险因素和当代管理趋势的多中心回顾性研究。
目标:
许多癌症患者需要中心静脉通路来促进化疗。中心静脉导管相关血栓形成 (CVCT) 是一种主要的并发症,可导致显着的发病率和死亡率。我们试图探索澳大利亚普通癌症人群中 CVCT 的发生率,并确定与血栓形成风险增加相关的因素。
设计:
这是一项多中心回顾性队列研究。
设置和参与者:
我们分析了 317 名癌症患者和插入中心静脉导管进行全身治疗的关键患者、治疗和癌症相关因素。
主要观察指标:
有症状的 CVCT 通过 CVCT 患者的影像学和管理得到证实。
结果:
共分析了 402 例中心线插入病例。24 名患者(6.0%)发生中心静脉导管相关血栓形成。与植入式端口相比,外周插入中心导管 (PICC; HR = 3.78, 95% CI = 1.28-11.19, P = .02),体重指数为 25.0 kg/m 2 (HR = 3.60, 95% CI = 1.31-9.85,P = .01)与血栓形成风险增加独立相关。中心静脉导管相关血栓形成主要通过拔除导管(24 例中的 19 例)和抗凝治疗,包括 5 例患者的直接作用口服抗凝剂。
结论:
这项工作探讨了普通癌症人群中 CVCT 的发生率,观察到 PICC 患者的发生率增加或体重指数增加。